Resources

This guide gives an overview of existing technologies available for diagnosis of SARS-CoV-2, the virus that causes COVID-19. This guide is complementary to policy guidance issued by the Indian Council of Medical Research (ICMR) and the World Health Organization (WHO).This guide may be useful to a wide range of stakeholders including:Ministries of Health (national, regional and district COVID-19 assigned personnel)Donors supporting diagnostic testing services for COVID-19.Public and private sector organizations with an interest in implementing SARS-CoV-2 diagnostic servicesHealth care providers involved in the diagnosis and management of COVID-19 cases

Research briefs in English and Portuguese on findings from a performance and operational use study of the SD Biosensor STANDARD™ G6PD Test in Brazil.The study shows that the SD Biosensor STANDARD G6PD Test performed well in comparison to the reference standard (spectrophotometry) which represents an important opportunity to improve Plasmodium vivax case management in malaria-endemic settings where reliable alternatives are needed to expand access to radical cure. The results of this study are relevant for the introduction of single-dose Kozenis in Brazil, which was approved in 2019.

To better understand the success factors and barriers to introducing the HPV vaccine at a national scale, PATH, in collaboration with the World Health Organization (WHO), undertook a cross sectional descriptive study of secondary data from HPV post-introduction evaluation (PIE) reports from a mix of 17 LMICs. Using a standardized form, planning and implementation data were extracted for 18 programmatic areas documented in countries’ PIE reports.The results of this report are presented below in an interactive dashboard, presentation, and fact sheet.Updated May 2022 to add Interactive Dashboard.

A brief on the current program, challenges with uptake, the potential impact of a reduced schedule, and the process from policy to implementation.

Relative to its population and other countries, Vietnam has experienced few COVID-19 cases, a testament to strategies by the Government of Vietnam to combat the pandemic. Quick action to limit foreign travel, contain outbreaks, and treat patients has meant that, throughout most of the pandemic, the people of Vietnam have been able to live life as normal. However, since July 2021, cases rose to levels of approximately 10,000 to 14,000 per day, and it is important to remain vigilant and constantly assess the strengths and weaknesses of the health system to ensure that any challenges presented by COVID-19 can be overcome.This report is an assessment on the state of medical oxygen and respiratory care equipment needed for COVID-19 patient treatment in Vietnam. In addition, because medical oxygen and respiratory care equipment are needed also for pneumonia, newborn conditions, asthma, heart failure, obstetric emergencies, and surgery, the findings from this report offer important lessons for improving the health system in general and preparing for the next pandemic.